Developer of a Ribonucleic Acid (RNA) therapeutics development platform designed to revolutionize cancer therapy and patient outcomes in oncology. The company's platform allows for direct inhibition o...

Healthcare
New Haven, CT, United States
Founded 2023
4 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$1.1M
Last Round
N/A

Get the full picture

Create a free account to unlock Cloverleaf Bio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required